Skye Bioscience, Inc. Cash And Cash Equivalents At Carrying Value

• Skye Bioscience, Inc. showed a decrease of -91.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Skye Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2011 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 12 years of available data (2011 to 2025), Skye Bioscience, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 42,177.5%.
• Historical annual values: Fiscal year 2025: $5.88 million | Fiscal year 2024: $68.42 million | Fiscal year 2023: $1.26 million | Fiscal year 2018: $1.85 million | Fiscal year 2017: $260.0 thousand | Fiscal year 2016: $64.8 thousand | Fiscal year 2015: $3.22 million | Fiscal year 2014: $207.3 thousand | Fiscal year 2014: $1.03 million | Fiscal year 2013: $52.2 thousand | Fiscal year 2012: $26.4 thousand | Fiscal year 2011: $13.9 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026